Abstract
Programmed death-1 (PD-1) critically regulates T cell tolerance, but the role of PD-1/PD-L1 in the pathogenesis of type 1 diabetes (T1D) patients remains unclear. In this study, we investigated circulating PD-1+/PD-L1+ T cells and their changes during the partial remission (PR) phase in T1D. 79 patients with T1D and 21 normal controls were enrolled, and grouped into 4 groups based on remission phase. The percentage of circulating PD-1+/PD-L1+ T cells, Treg, IL-35-Treg and Breg cells was analyzed by flow cytometry. The results showed that the expression of PD-1 in CD4+/CD8+ T cells was significantly decreased at the onset of T1D, and recovered to a high level during the remission phase. The honeymoon phase was accompanied by the increase of PD-1 expression, suggesting that PD-1 may be a new target for diagnosis and intervention. Disclosure T. Zhong: None. X. Li: None. Z. Zhou: None.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
